Drug Trial Radar · NCT06797999
First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
270
Planned (sponsor's estimate)
Start
Jun 5, 2025
Primary completion
Feb 27, 2029
Study completion Feb 27, 2029
Sponsor
- Lead sponsor
- Adcendo ApSIndustry
- Sponsor type
- Industry
- First posted
- Jan 29, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn about the safety, tolerability and efficacy of ADCE-D01.
Conditions
- Metastatic Soft Tissue Sarcoma
- Unresectable Soft Tissue Sarcoma
Interventions
Antibody-drug conjugate (ADC)Biological
ADCE-D01 is an antibody-drug conjugate (ADC) composed of an anti-urokinase plasminogen activator receptor-associated protein (uPARAP) antibody, AB-004, conjugated to a topoisomerase I inhibitor, P1021, via a protease cleavage tetra-peptide linker.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Determine the MTD/maximum administered dose and RP2DS of ADCE-D01.Time frame: From enrollment to the end of Phase 1b (Approximately 18 months after enrollment)
- Assess the safety and tolerability of ADCE-D01Time frame: Throughout the trial duration, completion expected approximately 18 months from completed enrollment
Locations
9 sites in 5 countries. Site status is shown where the registry gives one.
University of Colorado Denver
Aurora, Colorado · Recruiting
University of Miami - Sylvester Comprehensive Cancer Center
Miami, Florida · Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York · Recruiting
University Of Texas MD Anderson Cancer Center
Houston, Texas · Recruiting
Universitair Ziekenhuis Leuven (UZ Leuven) - Campus Gasthuisberg
Leuven, Belgium · Recruiting
Centre Léon Bérard
Lyon, France · Recruiting
Institut Gustave Roussy
Paris, Ville Juif Cedex, France · Not yet recruiting
Universitätsklinikum Essen West German Tumor Center
Essen, Germany · Recruiting
Royal Marsden
London, United Kingdom · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.